Search for Clinical Trials
A study to determine the change from baseline to post-treatment Ki67 in some breast cancer tissue.
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
This study is to see how ruxolitinib changes the breast cells when given to patients with premalignant breast conditions in order to know if it might…
The main purpose of this study is to look at the safety and effectiveness of the standard anti-HER2-targeted therapies.
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
This study is being done to see if losing weight may help prevent breast cancer from coming back.
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
The purpose of this study is to find out if adding simvastatin to dual anti-HER2 treatment can slow down the growth or reduce the size of your…
This study is being done to evaluate the safety and effectiveness of three different drug combinations for patients with HER2-positive metastatic…
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone.
Tucatinib is a type of drug…
